We are live on ! Find out more
GNPX icon

Genprex
GNPX

25 hedge funds and large institutions have $9.78M invested in Genprex in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

40% more call options, than puts

Call options by funds: $447K | Put options by funds: $319K

0% more ownership

Funds ownership: 0% → 0% (+0%)

11% less funds holding

Funds holding: 28 → 25 (-3)

38% less capital invested

Capital invested by funds: $15.8M → $9.78M (-$6.02M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
2
Closed
7
Calls
$447K
Puts
$319K
Net Calls
+$128K
Net Calls Change
+$315K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.5M
2
AFM
Anson Funds Management
Texas
+$834K
3
Renaissance Technologies
Renaissance Technologies
New York
+$584K
4
Millennium Management
Millennium Management
New York
+$250K
5
Group One Trading
Group One Trading
Illinois
+$167K

Top Sellers

Rank Fund Capital Flow
1
E
Ergoteles
New York
-$200K
2
HF
HRT Financial
New York
-$183K
3
GCP
GSA Capital Partners
United Kingdom
-$167K
4
Citadel Advisors
Citadel Advisors
Florida
-$83.4K
5
Simplex Trading
Simplex Trading
Illinois
-$83.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$27K – – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$25K – – –
Two Sigma Advisers
28
Two Sigma Advisers
New York
$25K – – –
Citadel Advisors
29
Citadel Advisors
Florida
$23K -$83.4K -1 Closed
NAS
30
Nicolet Advisory Services
Wisconsin
$20K – – –
OIA
31
OneDigital Investment Advisors
Kansas
$17K – – –
TRCT
32
Tower Research Capital (TRC)
New York
$17K – – –
ECM
33
ExodusPoint Capital Management
New York
$16K – – –
FIM
34
Freedom Investment Management
Connecticut
$14K – – –
Osaic Holdings
35
Osaic Holdings
Arizona
$11K – – –
Barclays
36
Barclays
United Kingdom
$7K – – –
Bank of America
37
Bank of America
North Carolina
$5K – – –
Wells Fargo
38
Wells Fargo
California
$4K -$83.4K -1 Closed
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$3K – – –
BC
40
Burleson & Co
California
$1K – – –
HNWAG
41
High Net Worth Advisory Group
Florida
$1K – – –
National Bank of Canada
42
National Bank of Canada
Quebec, Canada
$1K – – –
APA
43
American Portfolios Advisors
New York
$262 – – –
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$96 – – –
E
45
Ergoteles
New York
– -$200K -2 Closed
HF
46
HRT Financial
New York
– -$183K -2 Closed
HighTower Advisors
47
HighTower Advisors
Illinois
– -$70K -1 Closed
Simplex Trading
48
Simplex Trading
Illinois
– -$83.4K -1 Closed
Wolverine Trading
49
Wolverine Trading
Illinois
– -$83.4K -1 Closed
BRWM
50
B. Riley Wealth Management
Tennessee
– -$45K – –
1
2
3

GNPX Hedge Fund Activity: Q4 2021 in Review

25 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q4 2021, worth a combined $9.78M — down 38% from $15.8M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of GNPX and 4 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 8 added.

The largest buyer was Morgan Stanley, adding an estimated $1.5M. The largest seller was Ergoteles, exiting entirely with an estimated $200K sold.

  • 25 institutional investors held Genprex (GNPX) as of Q4 2021, down from 28 in Q3 2021.
  • Funds reported $9.78M of Genprex stock for Q4 2021, down 38% quarter-over-quarter.
  • 4 funds opened new Genprex positions in Q4 2021 and 7 closed out, a net change of -3 holders.
  • The largest Genprex buyer in Q4 2021 was Morgan Stanley, an estimated $1.5M added.
  • The largest Genprex seller in Q4 2021 was Ergoteles, an estimated $200K sold.

Based on aggregated 13F filings for Q4 2021.